Ono et al. discovered that inhibiting SCD1 using both the small molecule T-3764518 and SCD1 shRNA in colon cancer HCT-116 cells accelerated the autophagic process and activated AMPK, enabling the cancer cells to escape the cytotoxic effects of SCD1 inhibition [55]. Here, SCD is linked to cancer.